Health

All Posts in "Health"

Antimicrobial Resistance: NAFDAC Seeks Joint Efforts To Curb Threat

By Winifred Bosa

Director, Veterinary Medicine and Applied Products (VMAP) NAFDAC, Mrs. Adeoye Stephanie Temitayo, Deputy Director (i/c) Lagos Office, NAFDAC, Dr. Sigbeku Tunde and Dr. Bayor Adebola Ajayi, Snr.Manager Regulatory Affairs and Compliance, Zartech Limited. at the 2025 World Antimicrobial Awareness Week in Lagos recently.

The Director General of National Agency for Food and Drug Administration and Control NAFDAC, Prof. Mojisola Adeyeye has called for collaborative effort by critical stakeholders in the fight against Antimicrobial Resistance in the Nigeria medical ecosystem.

While antimicrobials remain indispensable tools for treating infections, Prof. Adeyeye noted that their misuse and overuse have accelerated the rise of resistancecompromising our ability to treat even common diseases.

According to a press release by Sayo Akintola

Resident Media Consultant, NAFDAC, Prof Adeyeye who was represented by her Special Assistant, Dr Gbenga Fajemirokun at the 2025 World Antimicrobial Awareness Week (WAAW) commemoration in Lagos avowed that the health of humans, animals, and our environment is inseparably linked, adding that stakeholders should reaffirm their collective commitment to addressing one of the most urgent and silent public health threats of our timeAntimicrobial Resistance (AMR).

Director, Drug Evaluation and Research (DER) NAFDAC, Mr. Amuda Kayode Isiaka, Special Assistant to the DG-NAFAC, Dr. Gbenga Fajmirokun and another attendee at the 2025 World Antimicrobial Awareness Week in Lagos recently.

She pointed out that the theme for this year, Act Now: Protect Our Present, Secure Our Future, is a powerful call to action, adding that it reminds us that the fight against AMR extends beyond hospitals and pharmacies; it also begins on our farms, in our veterinary clinics, and across our food production systems.

The choices we make todayboth in human and animal healthwill determine the health security of our nation for generations to come.’

In human health, the NAFDAC boss warned that AMR leads to treatment failures, prolonged illness, higher mortality rates, and increased risks during medical procedures.

In animal health and agriculture, she maintained that the indiscriminate use of antimicrobials for growth promotion, routine disease prevention, or unregulated application in aquaculture and crop farming has created a breeding ground for resistant pathogens.

According to the DG, these resistant bacteria can spread to humans through the food we consume, water sources, and direct contact with animals.

‘In effect, resistance anywhere is a threat everywhere.’

To protect our shared future, Prof Adeyeye said we must Act Nowby promoting sustainable agricultural practices, enforcing biosecurity, and encouraging good animal husbandry and responsible antimicrobial use.

As Nigerias regulatory authority for food, human and animal drugs, and allied products, she emphasised the pivotal role that NAFDAC plays in safeguarding public health, adding that the Agencys strategy to combat AMR is rooted in the One Health approach and implemented through a comprehensive, multi-sectoral framework.

She highlighted the four key priorities that guide the NAFDACs effort in combatting AMR which include strengthening regulation and surveillance, antibiotic stewardship in the community and hospitals, promoting rational use in animal care, engaging the agricultural value chain and public and professional enlightenment.

The NAFDC DG disclosed that the Agency is intensifying oversight of both human and veterinary antimicrobials, adding that this includes curbing the circulation of substandard and falsified veterinary drugs, enforcing compliance with quality standards, and strengthening pharmacovigilance and post-marketing surveillance systems.

She said NAFDAC is committed to ensuring that antimicrobials for animals are used strictly under veterinary supervision, only for treatmentnot for growth promotion or as a substitute for good farm practices.

‘We are working closely with the Federal Ministry of Livestock Development and the veterinary community to promote safer alternatives and ensure best practices.’

Prof Adeyeye further stated that NAFDAC is actively partnering with farmers, feed producers, veterinarians, and industry stakeholders to raise awareness and promote alternatives, such as vaccines, biosecurity measures, and improved farm management practices, noting that we are also regulating the use of antimicrobials in medicated feeds to prevent non-therapeutic use.’

Through nationwide campaigns, she said we are educating the public, farmers, and professionals alike. ‘Our message is simple: Responsible antimicrobial use is everyones responsibility. Protecting animals means protecting peopleand preserving the power of antimicrobials for the future.’

She urged healthcare professionals and veterinarians whom she described as the frontline defenders of public health to use antimicrobials judiciously and always under evidence-based guidance.

She however, urged the farmers and livestock producers to adopt good animal husbandry, hygiene, and vaccination practices to reduce the need for antibiotics.

She also admonished pharmacists to dispense antimicrobials only with valid prescriptions and educate consumers on responsible use.

To every Nigerian, she said; avoid self-medication, seek professional care, and demand responsibly produced food as she also urged media to continue to amplify awareness. ‘The story of AMR is one that must be toldclearly, urgently, and repeatedly.’

Prof Adeyeye envisions a Nigeria where infections in humans and animals remain treatable, our food chain is safe, and modern medicine continues to save livesis one we must build together.

‘That future is not assured; it must be earned through coordinated action and sustained vigilance.’

The NAFDAC boss reiterated that the fight against AMR will be won or lost based on our collective and coordinated efforts across the humananimalenvironment interface, adding that NAFDAC remains fully committed to playing its regulatory and leadership role with integrity, diligence, and innovation.

‘Let this years WAAW mark a renewed commitment to unity, collaboration, and sustained action. Together, let us Act Nowto protect our present and secure a healthier, safer, and more prosperous Nigeria.

Speaking in same vein, Director of the Veterinary Medicine and Allied Products Directorate of NAFDAC, Mrs. Temitayo Stephanie Adeoye noted with dismay that Antimicrobial Resistance (AMR) threatens the very foundation of modern medicine and food security.

She maintained that the overuse and misuse of antimicrobials in both human and animal health sectors, and the release of drug residues into the environment, have accelerated the emergence of resistant pathogens.

If not urgently addressed, she warned that the country risks returning to a time when minor infections could once again become fatal.

‘Our call to Act Now is a call to strengthen surveillance systems, enforce responsible antimicrobial use, and ensure the availability of safe, quality medicines through robust regulatory oversight, she said.

At NAFDAC, she further stated that through the Veterinary Medicine and Allied Products Directorate (VMAP) and other Directorates in the Agency ‘we continue to ensure that all medicinal products circulating within Nigeria are safe, effective, and of assured quality, adding that our team is leading inter-agency collaborations on AMR surveillance in the veterinary sector, promoting rational antimicrobial use, and integrating stewardship principles across the livestock and aquaculture value chains.

The Directorate also collaborates with partners under the One Health platform to harmonize data, enhance AMU/AMC reporting, and enhance laboratory capacities for AMR testing, ensuring that our interventions are science-based, traceable, and impactful.’

by Winifred Bosa — November 23, 2025 in Health

Nigeria’s Children At A Crossroads : New Report Shows Progress, But Millions Still Left Behind

By Winifred Bosa

As the world marks World Children’s Day 2025, UNICEF Nigeria is calling for renewed commitment to Nigeria’s youngest citizens, noting that while major challenges persist, significant progress has also been made to improve children’s lives.

According to the “Nigerian Child 2025 Report”, two out of every three children in Nigeria live in multidimensional poverty, meaning they lack access to essentials such as healthcare, quality education, nutrition, protection, and clean water.

The report also shows that more than half of all Nigerian children experience some form of violence before age 18, while two in five girls are married before turning 18.

The report also highlights strong progress in several areas. Over the past five years, Nigeria has expanded routine immunization coverage, launched nationwide campaigns to end child marriage, improved access to clean water for more than five million people, and enrolled more children in school than at any time in the last decade.

Led by government, and with generous support from development partners, UNICEF contributed to innovative social protection programmes, community-based nutrition drives, and media campaigns that continue to shift public attitudes on child rights.

UNICEF Nigeria Representative, Ms. Wafaa Saeed, said that while the statistics are sobering, they also reveal that progress is possible with coordinated effort.

“Behind every percentage lies a child whose potential is being stolen by poverty or neglect. But we are also seeing change, millions of children are getting vaccinated, millions are back in school, and more families are accessing clean water and social protection. These are victories worth celebrating,” she said.

Ms. Saeed added that this moment demands unity of purpose.

“It is time for all of us, government, development partners, donors, the private sector, and communities, to come together and put the Nigerian child at the top of every agenda. They are not just our responsibility, they are our future,” she emphasized.

Reflecting on Nigeria’s journey, Ms. Saeed noted that the country’s vast potential lies in its youth.

“With nearly half of Nigeria’s population under 18, the choices we make today will define the nation’s future. Every investment in children is an investment in peace, productivity, and progress,” she said.

World Children’s Day, celebrated each year on 20 November, marks the anniversary of the adoption of the Convention on the Rights of the Child (CRC) in 1989. The day serves as a global reminder of the need to protect, nurture, and empower every child to reach their full potential.

by Winifred Bosa — November 20, 2025 in Health

NAFDAC DG Celebrates Staff Over Landmark Achievements , Says Nigeria Remains Global Regulatory Leader

…. Rewards Officers with exceptional performances

By Winifred Bosa

The Director General of National Agency for Food and Drug Administration and Control NAFDAC, Prof Mojisola Adeyeye has attributed the milestones achieved by the Agency to the collective effort and resilience of staff which resulted in achieving WHO Global Benchmarking Tool (GBT) re-benchmarking, becoming the first in Africa to sustain and maintain Maturity Level 3 (ML3) for medicines regulation.

According to a press release by Sayo Akintola, Resident Media Consultant NAFDAC, She noted that the extraordinary feat reaffirms Nigerias leadership in the global regulatory landscape.

Speaking at the 2024 NAFDAC Awards, Recognition & Retirement Ceremony on Monday in Lagos, Prof Adeyeye said the event was not only to celebrate milestones but to honour the beating heart of NAFDAC – the committed and hardworking staff, whose dedication, resilience, and professionalism continue to define and sustain our Agencys legacy of excellence.
Each year, she said the ceremony ‘gives us a moment to pause, reflect, and appreciate how far we have come as one NAFDAC family, noting that ‘our achievements are not the result of chance, but of collective diligence, sacrifice, and shared purpose.’
According to the DG, every report written, every inspection conducted, every risk mitigated, and every regulation enforced contributes to a healthier, safer Nigeria.

The highly elated Chief Executive Officer of NAFDAC, pointed out that our Agency, under your collective effort, achieved WHO Global Benchmarking Tool (GBT) re-benchmarking, becoming the first in Africa to sustain and maintain Maturity Level 3 (ML3) for medicines regulation.’

She explained that The Agency also achieved another world-first as the first National Regulatory Authority globally to be benchmarked for Medical Devices and In-Vitro Diagnostics (IVDs) toward ML3 attainment.

She maintained that these milestones were not achieved by leadership alone, they were powered by teams of committed professionals who gave their best each day to ensure that our processes met WHOs stringent standards.

In 2024, she disclosed that the Agency also commissioned the state-of-the-art edifice for the Vaccine, Biologics, Medical Devices and IVDs Registration and Regulatory Affairs Directorate.

It is an investment in science, technology, and the future of health regulation ‘and it stands as a symbol of our resolve to institutionalize sustainability and innovation.’

Furthermore, she stated that the Agency sustained ISO/IEC 17025:2017 Laboratory Accreditation and achieved ISO 9001:2015 Re-Certification, affirming its unbroken commitment to quality and international best practices.

‘This could only have been possible through the hard work and diligence of our quality managers, laboratory analysts, and administrative teams who ensure compliance and continuous improvement.’

In parallel, the NAFDAC boss emphasised that incorporation of NAFDAC into the Pharmaceutical Inspection Co-operation Scheme (PIC/S) as a Pre-Applicant in the Pre-Accession phase is a milestone that positions Nigeria among nations that uphold harmonized GMP standards globally, adding that this opens new frontiers for Nigerias pharmaceutical manufacturing sector, ‘and again, it was made possible by your professionalism and competence.’

Prof Adeyeye also stated that the Agency intensified its enforcement operations in partnership with the
Office of the National Security Adviser (ONSA), shutting down major open drug markets, confiscating falsified medicines and destroying substandard products, adding that these courageous actions saved countless lives and reaffirmed public confidence in our regulatory system. ‘The success of these operations speaks to the bravery and integrity of our enforcement teams across Nigeria, she said

‘No achievement can be sustained without human capital development. That is why, under the International Council on Harmonization (ICH) training programmes, staff across directorates received advanced capacity-building sessions on ICHQ1, ICHQ7, E6(R3) and M13 Bioequivalence Studies guidelines.

These trainings reflect our unwavering investment in you, our people, because a skilled and motivated workforce is NAFDACs greatest asset.’
The proven implementation of these guidelines and other requirements has resulted in invitation of NAFDAC by ICH to become a member of the prestigious organization.
According to her, the awardees recognition is proof to excellence, consistency, and passion for service, adding that they have raised the bar and set new standards for others to emulate.

Let this recognition inspire you and your colleagues to continue striving for innovation, diligence, and excellence in all you do.
To our retirees, today is both a celebration and a tribute. You have devoted years, some, decades of your lives to building this institution.

You have guided the next generation with patience, integrity, and wisdom. Your footprints are indelible in the history of NAFDAC. As you enter this new chapter of rest and reflection, please know that your legacy lives on in the systems, policies, and culture you helped to build.

‘The global health landscape continues to evolve, and we must evolve with it, remaining agile, science-driven, and people-centered in all we do. You are the pillars of NAFDACs success, the silent heroes whose everyday work safeguards the lives of millions of Nigerians.’

Speaking in same vein, Chairman, 2024 NAFDAC Awards, Recognition & Retirement Ceremony, Dr. Rametu Momodu said over the years, NAFDAC has remained a beacon of hope for Nigerians, safeguarding lives through diligence, vigilance, and science-driven regulation. Dr Momodu who also doubles as Director, VMAP, noted that each success story we tell today is built upon the unwavering commitment of staff who give their best, often beyond the call of duty.

‘Our awardees embody this spirit. You represent the finest qualities of the Agency, resilience, professionalism, and integrity. Your innovative thinking and pursuit of excellence have made an indelible impact, not only within our institution but across Nigerias public health ecosystem, she said.

by Winifred Bosa — November 3, 2025 in Health

Inaction On Climate Change Takes Millions Of Lives, Says Lancet Countdown

By Winifred Bosa

WHO and global partners are calling for the protection of people’s health to be recognized as the most powerful driver of climate action, as a new global report released today warns that continued overreliance on fossil fuels and failure to adapt to a heating world are already having a devastating toll on human health.

According to a press release by WHO , the 2025 report of the Lancet Countdown on Health and Climate Change, produced in collaboration with the World Health Organization (WHO), finds that 12 of 20 key indicators tracking health threats have reached record levels, showing how climate inaction is costing lives, straining health systems, and undermining economies.

“The climate crisis is a health crisis. Every fraction of a degree of warming costs lives and livelihoods,” said Dr Jeremy Farrar, Assistant Director-General for Health Promotion and Disease Prevention and Care at the World Health Organization. “This report, produced with WHO as a strategic partner, makes clear that climate inaction is killing people now in all countries. However, climate action is also the greatest health opportunity of our time. Cleaner air, healthier diets, and resilient health systems can save millions of lives now and protect current and future generations.”

Key findings from the 2025 Lancet Countdown report

• Rising heat-related deaths: The rate of heat-related mortality has increased 23% since the 1990s, pushing total heat-related deaths to an average 546 000 deaths per year. The average person was exposed to 16 days of dangerous heat in 2024 that would not have been expected without climate change, with infants and older adults facing a total of over 20 heatwave days per person, a fourfold increase over the last twenty years.

• Wildfire and drought impacts: Droughts and heatwaves were associated with an additional 124 million people facing moderate or severe food insecurity in 2023.

• Economic strain: Heat exposure caused 640 billion potential labour hours to be lost in 2024, with productivity losses equivalent to US$ 1.09 trillion. The costs of heat-related deaths among older adults reached US$ 261 billion.

• Fossil fuel subsidies dwarf climate finance: Governments spent US$ 956 billion on net fossil fuel subsidies in 2023, more than triple the annual amount pledged to support climate-vulnerable countries. Fifteen countries spent more subsidizing fossil fuels than on their entire national health budgets.

• Benefits of climate action: There were an estimated 160 000 premature deaths avoided every year between 2010 and 2022, from reduced coal-derived outdoor air pollution alone. Renewable energy generation reached a record 12% of global electricity, creating 16 million jobs worldwide. Two-thirds of medical students received education in climate and health in 2024.

“We already have the solutions at hand to avoid a climate catastrophe – and communities and local governments around the world are proving that progress is possible. From clean energy growth to city adaptation, action is underway and delivering real health benefits – but we must keep up the momentum,” said Dr Marina Romanello, Executive Director of the Lancet Countdown at University College London. “Rapidly phasing out fossil fuels in favour of clean renewable energy and efficient energy use remains the most powerful lever to slow climate change and protect lives. At the same time, shifting to healthier, climate-friendly diets and more sustainable agricultural systems would massively cut pollution, greenhouse gases and deforestation, potentially saving over ten million lives a year.”

Health-promoting climate action

While some governments have slowed their climate commitments, the report shows that cities, communities and the health sector are leading the way. Nearly all reporting cities (834 of 858) have completed or plan to complete climate risk assessments. The energy transition is delivering cleaner air, healthier jobs, measurable economic growth and inward investment.

The health sector itself has shown impressive climate leadership, with health-related greenhouse gases (GHG) emissions falling 16% globally between 2021 and 2022, while improving care quality.

Data submitted by WHO show that a growing number of health systems are assessing risks and preparing for the dangerous future that’s coming. Fifty-eight% of Member States have completed a health Vulnerability and Adaptation assessment and 60% have completed a Health National Adaptation Plan.

Looking ahead to COP30: placing health at the centre of climate action

As the world prepares for COP30 in Belém, Brazil, the findings of the 2025 Global Report of the Lancet Countdown provide a key evidence base for accelerating health-centered climate action. WHO will build on this momentum through the forthcoming COP30 Special Report on Climate Change and Health, a collaborative effort highlighting the policies and investments needed to protect health, equity, and deliver the Belém Action Plan that is the expected landmark outcome of COP30.

The Lancet Countdown on Health and Climate Change was established in partnership with Wellcome, which continues to provide core financial support. The Lancet Countdown is led by University College London, in partnership with WHO and 71 academic institutions and UN agencies worldwide. Now in its ninth year, the report provides the most comprehensive assessment of the health impacts of climate change and the co-benefits of urgent action, ahead of COP30 in Brazil.

by Online Poster — October 29, 2025 in Health

NAFDAC Rolls Out Strategy , Roadmap For Trans-Fatty Acid Regulation

By Winifred Bosa

The National Agency for Food and Drug Administration and Control NAFDAC has launched the Strategy and Roadmap for Trans-Fatty Acid (TFA) Regulation in Nigeria.

This reaffirms her commitment to safeguarding public health by eliminating a dangerous dietary risk linked to heart disease, stroke, and premature death.

According to a press release by

Resident Media Consultant NAFDAC, Sayo Akintola ,the Director-General of NAFDAC, Prof. Mojisola Adeyeye, highlighted that Nigeria has already taken bold steps, including setting regulatory limits of no more than 2 grams of industrially produced trans fat per 100 grams of total fat or oil. In recognition of this effort, Nigeria was named by WHO in 2023 as one of seven countries that had adopted best-practice TFA elimination policies.

The newly launched roadmap outlines a phased approach focused on industry reformulation, laboratory strengthening, compliance monitoring, public education, and cross-sector collaboration. With support from partners such as Resolve to Save Lives, WHO, and other stakeholders, NAFDAC has also expanded its laboratory capacity to analyse TFAs, marking significant progress toward full implementation.

Prof. Adeyeye called on government agencies, industry, civil society, and consumers to work together to achieve WHO validation of Nigerias programme. Eliminating industrially produced trans fats is possible, achievable, and urgent.

With this roadmap, Nigeria is determined to protect the health of its citizens and secure a food supply free from the dangers of trans-fatty acids, she affirmed.

by Online Poster — October 27, 2025 in Health

Media Key To Combating Health Misinformation, Experts Declare At HEWAN, NIMR , Roche Workshop

By Winifred Bosa

In an era where misinformation on health issues spreads rapidly and widely, health experts have raised concern over the growing infodemic—the overwhelming wave of misleading or false health information that often confuses and endangers the public.

Recognizing the media’s pivotal role in bridging this information gap, journalists and media professionals have been identified as key catalysts in promoting factual, insightful, and balanced health reporting to help Nigerians make informed decisions about their well-being.

This formed the central focus of discussions at a two-day capacity-building workshop organized by the Health Writers Association of Nigeria (HEWAN) in collaboration with the Nigerian Institute of Medical Research (NIMR) and Roche.

The workshop , themed : “Elevating Science and Health Journalism”, brought together journalists, health experts, and communication professionals to explore strategies for strengthening health and science journalism in Nigeria.

In his opening remarks, Professor John Obafunwa, the Director-General of Nigerian Institute of Medical Research (NIMR), represented by the Director of Research NIMR, Professor Oliver Ezechi, emphasized the need for collective commitment to improving the quality, integrity, and public value of health journalism in Nigeria.

Obafunwa described the gathering as a reflection of shared dedication to strengthening the profession.

He noted that the values of integrity and accuracy in health reporting have been central to his career and should continue to guide media professionals in the years ahead.

“Today’s convergence comes at a watershed moment for health journalism in Nigeria,” he said.

“We live in an era of rapid scientific advancement and expanding health knowledge, yet we continue to face persistent challenges — from infectious diseases that demand future surveillance to the growing burden of non-communicable conditions requiring sustained lifestyle, policy, and clinical responses.”

The NIMR chief stressed the importance of ensuring that Nigerians have continued access to trustworthy health and scientific insights capable of informing personal decisions, guiding policy development, and strengthening the nation’s health systems.

According to him, journalists play a vital role in building public trust, reducing misinformation, and making complex scientific issues understandable to the public.

“Through enforcing trust, reducing uncertainty where possible, and explaining complexities in accessible terms, we can empower citizens to make informed choices that improve their lives and communities,” he said.

“Leadership in health is not the sole responsibility of any single organization or individual,” Obafunwa added. “It is a collaborative venture anchored on shared vision, mutual trust, and sustained cooperation. Our strength lies in enduring partnerships among media houses, research institutions, health agencies, professional associations, and civil society organizations.”

Delivering the keynote lecture at the workshop on the topic, “Why Health and Science Journalism Matters More Than Ever In Nigeria ” , Professor Oliver Ezechi underscored the critical role of the media as a public health tool, stressing that access to accurate information can save lives.

“Access to accurate information saves lives,” he said. “When journalists provide clear and verified reports, they enable people to make informed choices about vaccines, medications, and preventive practices. Investigative health journalism also exposes gaps in service delivery, driving accountability and prompting corrective actions.”

Ezechi observed that the growing challenges of infodemics, climate-related health threats, and complex scientific innovations make it imperative for journalists to stay informed and responsible in their reporting.

“In moments of crisis—whether during outbreaks, heat waves, or mental health emergencies—journalists play a vital role in translating complex data into practical, timely information that communities can act upon,” he stated. “Accurate health reporting informs decisions, protects vulnerable populations, and advances national progress.”

Urging media professionals to renew their commitment to accuracy, context, and public service, he emphasized that credible journalism remains essential to safeguarding public health and strengthening Nigeria’s development agenda.

In her welcome address at the occasion, President of the Health Writers Association of Nigeria (HEWAN), Mrs. Vivian Ihechu, called on journalists to deepen their commitment to accurate and impactful health reporting, stressing that quality journalism plays a vital role in saving lives and shaping better public health outcomes.

She made the call during a workshop organized by HEWAN in collaboration with the Nigerian Institute of Medical Research (NIMR) and Roche, held in commemoration of the 2025 Breast Cancer Awareness Month. The theme of the event was “Elevating Science and Health Journalism.”

Ihechu said the workshop was designed to build the capacity of health journalists in Nigeria to effectively translate scientific data into information the public can understand and act upon.

“Journalism is not just about reporting facts; it’s about saving lives,” she stated. “In a country grappling with complex public health challenges, your expertise in translating scientific data into actionable public information is invaluable.”

She noted that the training, supported by NIMR and Roche, would equip journalists with advanced tools to cover issues such as disease outbreaks, policy changes, and medical innovations with accuracy and depth.

Ihechu emphasized that the event also aligns with the global fight against breast cancer, highlighting the need for early detection, equitable access to screening and treatment, and the dispelling of harmful myths that hinder timely intervention.

“October serves as a critical reminder that breast cancer remains a devastating threat to our mothers, sisters, and daughters,” she said. “As journalists, we must go beyond the statistics to tell the stories that inspire action and save lives.”

She expressed appreciation to NIMR and Roche for their unwavering support and partnership, noting that their collaboration demonstrates a shared commitment to improving public health through informed reporting.

by Winifred Bosa — October 24, 2025 in Health

WHO Raises Alarm Over Tobacco Industry’s Attempt To Weaken Anti-Smoking Policies

By Winifred Bosa

The Secretariat of the WHO Framework Convention on Tobacco Control (WHO FCTC) is alerting governments and the public that the tobacco industry is intensifying efforts to interfere with the work of the Conference of the Parties (COP), the treaty’s decision-making body, to weaken global tobacco control measures.

As was contained in a press release by WHO , the WHO FCTC is the first treaty negotiated under the auspices of WHO and one of the most widely and rapidly embraced United Nations treaties in history. A total of 183 Parties have joined the Convention, which entered into force 20 years ago.

The Eleventh session of the COP, which will be held from 17-22 November in Geneva, Switzerland, will bring together Parties to the Convention to take the decisions necessary to work towards achieving the objectives of the WHO FCTC, including the discussion of measures to prevent nicotine addiction, and for the protection of the environment and human health, among others.

The Meeting of the Parties (MOP), which will take place in Geneva, Switzerland from 24-26 November, serves as the governing body of the Protocol to Eliminate Illicit Trade in Tobacco Products—an international treaty that entered into force in 2018 and has 71 Parties. At the MOP, Parties will consider a range of measures aimed at shaping the future of the Protocol and its role in eliminating illicit trade in tobacco products.

“With strategies varying from lobbying to outright attempts to manipulate delegations, the tobacco industry’s tactics are a cause for serious concern,” said Andrew Black, Acting Head of the Secretariat of the WHO FCTC.

“This is not just lobbying; it is a deliberate strategy to try to derail consensus and weaken measures to further the treaty’s implementation. Tobacco industry interference is one of the biggest constraints and barriers to the implementation of the Convention. The Secretariat strongly urges Parties, civil society and other stakeholders working to support tobacco control to remain vigilant against the industry’s tactics and misinformation. Governments have obligations under the WHO FCTC to fully implement Article 5.3, requiring the protection of public health policies from the commercial and other vested interests of the tobacco industry.”

Evidence from independent civil society actors, including those that are observers to the Conference of the Parties, shows the industry’s interference includes:

Political capture: Attempting to place sympathetic actors in national delegations or influence their selection to sway negotiations.

Front groups and “independent” voices: Industry-funded organisations posing as trade, science, or consumer groups to lobby delegations.

Co-opting science: Sponsoring or promoting misleading research to cast doubt on proven tobacco control measures.

Economic narratives: Pressuring finance and trade ministries with misleading claims about jobs, farming, and tax revenues.

Access infiltration: Attempting to gain observer status or participate in COP-related events to influence discussions.

These tactics mirror those documented in the Global Tobacco Industry Interference Index, which reports on tobacco industry interference globally.

The WHO FCTC Secretariat urges all Parties to:

Fully implement Article 5.3 of the WHO FCTC and its Guidelines for implementation, covering all branches of government from tobacco industry influence.

Protect COP from the commercial and other vested interests of the tobacco industry in line with Objective 3.1.3 of the Global Strategy to Accelerate Tobacco Control: Advancing sustainable development through the implementation of the WHO FCTC 2019-2030, including during the preparation of country delegations.

Ensure their COP and MOP delegations do not include tobacco industry or tobacco industry-affiliated persons.

Reject any industry-linked funding or partnerships, including for COP and MOP activities or national delegations.

Educate non-health ministries on industry tactics and Article 5.3 obligations.

Use available monitoring tools like the Global Tobacco Industry Interference Index to detect interference.

by Online Poster — October 23, 2025 in Health

Roche Collaborates With Health Writers To Boost Breast Cancer Awareness

By Winifred Bosa

Roche Nigeria has partnered with Health Writers’ Association of Nigeria ( HEWAN ) to boost breast cancer education and media reporting in recognition of Breast Cancer Awareness Month .

To commemorate this , a strategic capacity-building workshop for health journalists was held at the Cancer Centre, Nigerian Institute for Medical Research (NIMR) in Lagos .

The workshop was designed to equip journalists with the necessary tools to accurately inform the Nigerian public about the realities of breast cancer and the available care initiatives.

Key sessions at the workshop included:

1. An expert overview of breast cancer, presented by Dr. Samuel Otene, a Consultant Radiation and Clinical Oncologist and State Chairman, Nigerian Cancer Society, Benue Chapter.

2. A presentation on the Presidential Directive for Mandatory Health Insurance and its implications for transforming healthcare in Nigeria by Dr Amade-Agada, GM Standards & Quality Assurance, National Health Insurance Authority (NHIA)

3. . A detailed briefing on the Africa Breast Cancer Ambition (ABCA), an ongoing mission by Roche and its partners to improve breast cancer care outcomes.

Pharm. Gilbert Ogbewele, Marketing and Business Support Lead representing the General Manager Dr. Ladi Hameed, addressed the journalists highlighting their essential role. “Roche is proud to partner with HEWAN, a truly critical stakeholder entrusted with preserving public interest. Your role in educating the Nigerian public about the scourge of breast cancer is invaluable,” Ogbewele stated.

“Crucially, you offer hope by arming our citizens with information about the available policies and breast cancer care initiatives that are functional in Nigeria today.”

The workshop aims to leverage the media’s reach to drive increased awareness, encourage early detection, and support the strengthening of Nigeria’s healthcare system for improved cancer care and survival. Mr. Ogbewele also noted that journalists are critical in supporting the government’s drive toward universal health coverage.

This initiative is part of Roche’s bold Africa Breast Cancer Ambition (ABCA), a mission dedicated to rewriting the story of breast cancer in Nigeria. Roche invited the media to join the quest to make a real difference in the essential fight against breast cancer.

by Winifred Bosa — October 22, 2025 in Health

Clinical Trial : NAFDAC , NNMDA Chart Path For Safe, Effective Nigerian Herbal Medicines

By Winifred Bosa

The National Agency for Food and Drug Administration and Control (NAFDAC) is collaborating with the Nigeria Natural Medicine Development Agency (NNMDA) to develop scientifically proven, safe and effective herbal medicines that meet global standards through clinical trials.

According to a press release by Sayo Akintola , Resident Media Consultant, NAFDAC , the Director General of NAFDAC, Prof. Mojisola Adeyeye, who dropped the hint, disclosed that Nigerian herbal medicine practitioners have the capacity to formulate safe and effective indigenous natural remedies that meet international standards.

NAFDAC has two types of approval for herbal medicines. The first type is a listing (L) approval, and it is granted after the product has been evaluated in our laboratory for toxicology safety tests with satisfactory results. Products in this approval category are listed for a period of two years, with a NAFDAC number bearing the letter L at the end.

The second approval type requires that clinical trials be conducted on the product to prove the efficacy of such a product. If this is done (in a well-designed protocol) with proven efficacy, a full approval with five-year validity is given.

The Director General identified cost as a major obstacle preventing herbal medicine practitioners from subjecting their products to clinical trials.

‘If you have an herbal medicine that you cannot prove scientifically the extent to which it works without causing harm to the user by providing some data on the efficacy, then it cannot be fully registered by NAFDAC.

Prof Adeyeye disclosed that NAFDAC has listed thousands of herbal medicines, with only a few products that have gone through clinical trial outcomes, But we cannot give 5-year approval without passing the efficacy test through a clinical trial.

We know that herbal medicine works. It is how to ascertain through clinical trial the level it can be used below which patients will be safe, and above which there could be damage to the liver, the kidney, and other internal organs, she explained, emphasising that the fact that its natural doesnt mean that its all safe. Thats where NAFDAC regulation and control come in.

The DG recalled that NAFDAC launched the Herbal Medicine Products Committee just before the COVID-19 Pandemic, which brought the practitioners, the Ministry of Health, NAFDAC and researchers together. This collaborative effort is very important because the practitioners know what their forefathers have been using, while the researchers know the science.

According to her, the Agency is looking for funding to assist the practitioners in the conduct of clinical trials, which is highly capital-intensive.

She pointed out that the Agency is working assiduously with the NNMDA to ensure that clinical trial is conducted for the medicines that have met the regulatory requirements for listing.

She said that NAFDAC is working together with the NNMDA to use some selected listed herbal medicines to conduct clinical trials, so that we will prove beyond doubt that the medicine works well and those can now be registered fully.

Such medicines can be placed in a national formulary for herbal medicines, even if there are few.

She stated that NAFDAC has been educating the herbal medicine practitioners who intend to register products through stakeholders meetings.

The Agency even published a simple floor plan on the website as a guide for the practitioners.

She averred that it does not necessarily have to be a big place to use for production. She, however, maintained that the factory must be well-ordered to allow a good workflow so that there will not be contamination.

We are working with our practitioners. We are approving herbal medicines daily in NAFDAC, but we are working towards a phase where we will have a national formulary for those that have had clinical trials and have been proven to be very effective, she said.

The Director-General disclosed that before her appointment at NAFDAC, she was a professor in the United States. While at the university, she led a project that developed an anti-sickling polyherbal medicine.

This medicine, which NAFDAC had listed many years before her tenure, was tested in laboratory settings by incubating it with blood samples from children with sickle cell disease to prove its anti-sickling effect.

Two research papers were published, confirming both the anti-sickling and anti-infective properties of the medicine.

We conducted a clinical trial approved by the Ethics Committee of Bowen University and the Institutional Review Board of my University in the U.S on the polyherbal in July before my assumption of office in NAFDAC in November 2017.

She added that the trial showed that the product was efficacious but needed more data and funding for completion.

We are determined to assist our practitioners in the area of clinical trials and together with NNMDA we shall mobilise resources to get some herbal medicines fully registered after going through due process, she said.

by Winifred Bosa — October 12, 2025 in Health

New Recommendations To Help End Deaths From Postpartum Haemorrhage —Global Health Agencies

Through landmark new guidelines released , leading reproductive health agencies are calling for a major shift in how postpartum haemorrhage (PPH) is prevented, diagnosed and treated.

According to a press release by WHO ,the recommendations highlight the urgent need for earlier detection and faster intervention — steps that could save the lives of tens of thousands of women each year.

Defined as excessive bleeding after childbirth, PPH affects millions of women annually and causes nearly 45 000 deaths, making it one of the leading causes of maternal mortality globally. Even when not fatal, it can lead to lifelong physical and mental health impacts, from major organ damage to hysterectomies, anxiety and trauma.

“Postpartum haemorrhage is the most dangerous childbirth complication since it can escalate with such alarming speed. While it is not always predictable, deaths are preventable with the right care,” said Dr Jeremy Farrar, Assistant Director-General for Health Promotion and Disease Prevention and Care. “These guidelines are designed to maximize impact where the burden is highest and resources are most limited – helping ensure more women survive childbirth and can return home safely to their families.”

New diagnostic criteria for rapid action

Published by the World Health Organization (WHO), the International Federation of Gynecology and Obstetrics (FIGO) and the International Confederation of Midwives (ICM), the guidelines introduce new objective diagnostic criteria for detecting PPH, based on the largest study on the topic to date – also published today in The Lancet.

Many PPH cases occur without identifiable risk factors, meaning early detection and rapid response is critical. Yet in many settings, especially where healthcare resources and labour wards are overstretched, delays in treatment result in devastating consequences.

Typically, PPH has been diagnosed as a blood loss of 500 mL or more. Now, clinicians are also advised to act when the blood loss reaches 300 mL, and any abnormal vital signs have been observed. To diagnose PPH early, doctors and midwives are advised to monitor women closely after birth and use calibrated drapes – simple devices that collect and accurately quantify lost blood – so that they can act immediately when criteria are met.

The guidelines recommend the immediate deployment of the MOTIVE bundle of actions once PPH has been diagnosed. This includes:

Massage of the uterus;
Oxytocic drugs to stimulate contractions;
Tranexamic acid (TXA) to reduce bleeding;
Intravenous fluids;
Vaginal and genital tract examination; and
Escalation of care if bleeding persists.
In rare cases where bleeding continues, the guidelines also recommend effective interventions such as surgery or blood transfusion to safely stabilize a woman’s condition until further treatment becomes available.

“Women affected by PPH need care that is fast, feasible, effective and drives progress towards eliminating PPH-related deaths,” said Professor Anne Beatrice Kihara, President of FIGO. “These guidelines take a proactive approach of readiness, recognition and response. They are designed to ensure real-world impact – empowering health workers to deliver the right care, at the right time, and in a wide range of contexts.”

Reducing risks through effective prevention

The guidelines emphasize the importance of good antenatal and postnatal care to mitigate critical risk factors such as anaemia, which is highly prevalent in low- and lower-middle income countries. Anaemia increases the likelihood of PPH and worsens outcomes if it occurs. Recommendations for anaemic mothers include daily oral iron and folate during pregnancy and intravenous iron transfusions when rapid correction is needed, including after PPH, or, if oral therapy fails.

The publication also discourages unsafe practices such as routine episiotomies while promoting preventive techniques like perineal massage in late pregnancy, so as to reduce the likelihood of trauma and severe bleeding after birth.

During the third stage of labour, the guidelines recommend administering a quality-assured uterotonic to support uterine contraction, preferably oxytocin or heat-stable carbetocin as an alternative. If intravenous options are not available and the cold chain is unreliable, misoprostol may be used as a last resort.

“Midwives know first-hand how quickly postpartum haemorrhage can escalate and cost lives,” said Professor Jacqueline Dunkley-Bent OBE, ICM’s Chief Midwife. “These guidelines are a game-changer. But to end preventable deaths from PPH, we need more than evidence and protocols. We call on governments, health systems, donors, and partners to step up, adopt these recommendations, adopt them quickly, and invest in midwives and maternal care so that postpartum haemorrhage becomes a tragedy of the past.”

The guidelines are accompanied by a suite of training and implementation resources, developed with partners including UNFPA. These tools consist of practical modules for frontline health workers, national-level guides for introducing new practices, and simulation-based training to strengthen emergency response.

These consolidated guidelines–the first to uniquely focus on PPH–are being launched at the 2025 FIGO World Congress in Cape Town, South Africa. They are a crucial step in the implementation of the Global Roadmap for Combatting PPH between 2023 and 2030.

by Online Poster — October 7, 2025 in Health